Does a low frequency of P53 and Pgp expression in familial glioma compared to sporadic controls indicate biological differences?

Anticancer Research

Volumn 22, Issue 6 C, 2002, Pages 3949-3954

  Malmer, Beatrice ^a,b   Brännström, Thomas ^a   Andersson, Ulrika ^a   Bergh, Kerstin ^a   Grönberg, Henrik ^a   Henriksson, Roger ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Astrocytoma; Phenotype; Primary brain tumors

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; PROTEIN P53; VASCULOTROPIN;

ADULT; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FAMILIAL CANCER; FAMILIAL GLIOMA; FAMILY HISTORY; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENDOTHELIAL GROWTH FACTORS; FEMALE; GLIOMA; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; LYMPHOKINES; MALE; MIDDLE AGED; P-GLYCOPROTEIN; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036875967     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Li FP and Fraumeni Jr JF: Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst 43: 1365-73, 1969.
2. Li YJ, Sanson M, Hoang-Xuan K, Delattre JY Poisson M, Thomas G et al: Incidence of germ-line p53 mutations in patients with gliomas. Int J Cancer 64: 383-7, 1995.
3. Tachibana I, Smith JS, Sato K, Hosek SM, Kimmel DW and Jenkins RB: Investigation of germiline pten, p53, p16(ink4a)/p14(arf), and cdk4 alterations in familial glioma. Am J Med Genet 92: 136-41, 2000.
4. Vieregge P, Gerhard L and Nahser HC: Familial glioma: occurrence within the "familial cancer syndrome" and systemic malformations. J Neurol 234: 220-32, 1978.
5. Grossman SA, Osman M, Hruban R and Piantadosi S: Central nervous system cancers in first-degree relatives and spouses. Cancer Invest 17: 299-308, 1999.
6. Malmer B, Grönberg H, Bergenheim AT, Lenner P and Henriksson R: Familial aggregation of astrocytoma in Northern Sweden: an epidemiological cohort study. Int J Cancer 81: 366-70, 1999.
7. Wrensch M, Lee M, Miike R, Newman B, Barger G, Davis R et al: Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol 145: 581-93, 1997.
8. Kleihues P and Cavanee WK: In: Kleihues P, Cavanee K, editors. Pathology and Genetics, Tumours of the Nervous System. Lyon: 2000: 6.
9. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P et al: Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A: 2474-84, 1996.
10. Freedman AN, Michalek AM, Marshall JR, Mettlin CJ, Petrelli NJ, Black JD et al: Familial and nutritional risk factors for p53 overexpression in colorectal cancer. Cancer Epidemiol Biomarkers Prev 5: 285-91, 1996.
11. Paunu N, Syrjakoski K, Sankila R, Simola KO, Helen P, Niemela M, Matikainen M, Isola J and Haapasalo H: Analysis of p53 tumor suppressor gene in families with multiple glioma patients: J Neurooncol Dec 55(3): 159-65, 2001.
12. Louis DN: A molecular genetic model of astrocytoma histopathology. Brain Pathol 7: 755-64, 1997.
13. Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P and Ohgaki H: Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6: 217-23, 1996.
14. Leung DW, Cachianes G, Kuang WJ, Goeddel DV and Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 546: 1306-9, 1989.
15. Lindgren M, Johansson M, Sandstrom J, Johnsson Y, Bergenheim AT and Henriksson R: VEGF and TPa co-expressed in malignant glioma. Acta Oncol 36: 615-8, 1997.
16. Leon SP, Folkerth RD and Black PM: Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77: 362-72, 1996.
17. von Bossanyi P, Diete S, Dietzmann K, Warich-Kirches M and Kirches E: Immunohistochemical expression of p-glycoprotein and glytathione s-transferases in cerebral gliomas and response to chemotherapy. Acta Neuropathol (Berl) 94: 605-11, 1997.
18. Nutt CL, Noble M, Chambers AF and Cairncross JG: Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res 60: 4812-8, 2000.
19. Ashmore SM, Thomas DG and Darling JL: Does p-glycoprotein play a role in clinical resistance of malignant astrocytoma? [editorial]. Anticancer Drugs 10: 861-72, 1999.
20. Bogler O, Huang HJ, Kleihues P and Cavenee WK: The p53 gene and its role in human brain tumors. Glia 15: 308-27, 1995.
21. Baas IO, Mulder JW, Offerhaus GJ, Vogelstein B and Hamilton SR: An evaluation of six antibodies for imunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172: 5-12, 1994.
22. Lang FF, Miller DC, Koslow M and Newcomb EW: Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 81: 427-36, 1994.
23. Hussain SP and Harris CC: Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens. Mutant Res 462: 311-22, 2000.
24. Sawada T, Kato Y, Sakayori N, Takekawa Y and Kobayashi M: Expression of the multidrug-resistance P-glycoprotein (Pgp, mdr-1) by endothelial cells of the neovasculature in central nervous system tumors. Brain tumor Pathology 16: 23-7, 1999.
25. Coley HM, Verrill MW, Gregson SE, Odell DE, Fisher C and Judson IR: Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma. Eur J Cancer 36: 881-8, 2000.
26. Ralhan R, Swain RK, Agarwal S, Kaur J, Nath N, Sarkar G et al: P-glycoprotein is positively correlated with p53 in human oral premalignant and malignant lesions and is associatd with poor prognosis. Int J Cancer 84: 80-5, 1999.
27. Lanyi A, Deb D, Seymour RC, Ludes-Meyers JH, Subler MA and Deb S: "Gain of function" phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain. Oncogene 16: 3169-76, 1998.